GCG and type 2 diabetes mellitus: Liraglutide (Lira) or NN2211 is a recombinant palmityl-acylated derivative of glucagon like peptide −1 (GLP1), which was approved for the treatment of T2DM (6) in addition to chronic weight management (7).